drugset / Trial / NCT00655733
Phase II Study of HMPL-004 in Subjects With Crohn's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A double blind, randomized, multi-center, placebo-controlled study to evaluate the efficacy and safety of HMPL-004 in patients with active moderate Crohn's Disease.
Timeline
- Start
- 2006-04
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | andrographolide | Small molecule | 1200 mg | Oral |